2 days ago
Morgan Stanley Sticks to Their Buy Rating for COSMOS Pharmaceutical Corporation (3349)
In a report released today, Ai Furukawa from Morgan Stanley maintained a Buy rating on COSMOS Pharmaceutical Corporation (3349 – Research Report), with a price target of Yen10,400.00. The company's shares closed today at Yen9,062.00.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Furukawa is an analyst with an average return of -5.5% and a 60.00% success rate. Furukawa covers the Consumer Cyclical sector, focusing on stocks such as ABC-MART, Asics, and Isetan Mitsukoshi Holdings.
Currently, the analyst consensus on COSMOS Pharmaceutical Corporation is a Hold with an average price target of Yen9,825.00, which is an 8.42% upside from current levels. In a report released on June 13, Citi also maintained a Buy rating on the stock with a Yen11,200.00 price target.
